Product Description:

• Aimovig is a prescription medicine used to help prevent migraine in adults.


• Aimovig is the first FDA-approved treatment that blocks the CGRP receptor to help prevent migraine.

How To Use:

For subcutaneous use only

• Recommended dosage is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly.


• Administer in the abdomen, thigh, or upper arm subcutaneously.


• Recommended dosage is 70 mg once monthly; some patients may benefit from a dosage of 140 mg once monthly.


• Administer in the abdomen, thigh, or upper arm subcutaneously.

Warnings And Precautions:

• Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig.

Before starting Aimovig, tell your healthcare provider (HCP) about all your medical conditions, including:

• If you are allergic to rubber or latex.


• Pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.


• Tell your hcp about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

Ingredients:

• 70 mg/mL solution in a single-dose prefilled SureClick® autoinjector

Product Details:

• Product Form: pre-filled subcutaneous injection
• Product Type: Pen
• Brand: Aimovig